Amble Health vs Mochi Health vs OrderlyMeds (2026)

On tirzepatide, the order is Mochi Health↗ ($278) → OrderlyMeds↗ ($299) → Amble Health ($300) — gaps of $21 and then $1 a month, a $264 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

Mochi Health: the record, condensed

Mochi Health’s tirzepatide program bills $278 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

A required $79/month membership is part of the deal, and part of the figure above: $199 of medication plus $79 of platform equals the $278 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

On semaglutide, the number that matters at Mochi Health is $178 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

A required $79/month membership is part of the deal, and part of the figure above: $99 of medication plus $79 of platform equals the $178 that leaves your account. Judge the membership by what it includes, but compare on the total.

Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

OrderlyMeds: the record, condensed

OrderlyMeds’s tirzepatide program bills $299 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes OrderlyMeds unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #8 of 17 in the verified tirzepatide index — $84/month above the floor (NexLife, $215) — and sits $150 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,588.

OrderlyMeds’s semaglutide program bills $149 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at OrderlyMeds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #4 of 20 verified programs, with the floor $16/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $200 a month. A year at this figure: $1,788 monthly-billed.

Operationally at OrderlyMeds: shipping included; commitment none stated; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence no public price, captured 2026-08-05. The full record with source and archive links: the OrderlyMeds page · visit OrderlyMeds ↗

Amble Health: the record, condensed

Start with the load-bearing figure: $300 a month, all-in, is what Amble Health charges for tirzepatide at the 10 mg basis. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

There is no membership line. $300 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #9 of 17 in the verified tirzepatide index — $85/month above the floor (NexLife, $215) — and sits $149 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,600.

Operationally at Amble Health: shipping unknown; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Amble Health page

§ The three-way read

Prices, gaps, and what sits inside them

Mochi Health holds the low ground at $278 — dose-flat, so that figure is a ceiling (its $79 membership already inside). OrderlyMeds follows at $299 (+$21/mo, $252/yr). Amble Health tops the trio at $300 (+$22/mo over the leader, $264/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles the order: OrderlyMeds $149 → Mochi Health $178 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: Mochi Health ($278); cheapest 12-month path: Mochi Health ($3,336); simplest billing (no membership): OrderlyMeds and Amble Health; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: OrderlyMeds ($149).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Mochi Health vs OrderlyMeds · Mochi Health vs Amble Health (record · record) · OrderlyMeds vs Amble Health (record · record).

§ Structure, three ways

Everything besides the three prices

Memberships: Mochi Health $79/mo (inside its figure); OrderlyMeds none; Amble Health none. Structures: Mochi Health dose-flat; OrderlyMeds dose-flat; Amble Health dose-flat. Pharmacies: Mochi Health named (company-owned compounding facility); OrderlyMeds not named; Amble Health not named. States: Mochi Health — most states; OrderlyMeds — not published; Amble Health — not published. Exit terms: Mochi Health — cancel membership any time; recurs until cancelled; OrderlyMeds — not published; Amble Health — not published.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Mochi Health source-verified (2026-08-05); OrderlyMeds no public price (2026-08-05); Amble Health third-party reported (2026-08-05).

The trio on semaglutide, across time

3 mo: OrderlyMeds $447 vs Mochi Health $534 6 mo: OrderlyMeds $894 vs Mochi Health $1,068 12 mo: OrderlyMeds $1,788 vs Mochi Health $2,136 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

Mochi Health: $3,336/yr monthly-billed; OrderlyMeds: $3,588/yr monthly-billed; Amble Health: $3,600/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $528 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

Work it as eliminations rather than a beauty contest. Amble Health enters owing an explanation: $22/month above Mochi Health compounds to $264 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. OrderlyMeds survives the first cut only to face the harder question — whether nothing structural — its case is purely situational is worth $21 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. Mochi Health is what remains: the arithmetic answer at $278, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.

The same trio on best published rate: Mochi Health $278 → OrderlyMeds $299 → Amble Health $300 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Mochi Health $834, OrderlyMeds $897, Amble Health $900; 6 months — Mochi Health $1,668, OrderlyMeds $1,794, Amble Health $1,800. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): Mochi Health 5/5 · OrderlyMeds 3/5 · Amble Health 3/5. The gap between Mochi Health (5/5) and OrderlyMeds (3/5) is itself information: undisclosed axes are where the questions in each provider’s review earn their keep. The concrete splits — pharmacy named: Mochi Health yes, OrderlyMeds and Amble Health no — convert directly into pre-purchase emails. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.

The three-way verdict compresses cleanly: Mochi Health is the default on arithmetic; OrderlyMeds earns the middle only where its structure (flat pricing) solves something the floor does not; and Amble Health’s $22/month premium over the leader — $264 a year, roughly 0.9 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.